ASX - By Stock
|
AQZ |
Re:
Ann: Alliance signs E190 capacity deal with QANTAS
|
|
thestrategist5
|
13 |
3.5K |
2 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
13
|
3.5K
|
2
|
|
ASX - By Stock
|
ASN |
Re:
ASN Chart
|
|
thestrategist5
|
10K |
3.5M |
16 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
10K
|
3.5M
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
thestrategist5
|
555 |
270K |
8 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
270K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
thestrategist5
|
635 |
280K |
27 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
280K
|
27
|
|
ASX - By Stock
|
TEG |
Re:
State Gas Limited (ASX: GAS) – Trading Halt
|
|
thestrategist5
|
276 |
72K |
6 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
276
|
72K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
thestrategist5
|
2.0K |
702K |
6 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
702K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
thestrategist5
|
854 |
435K |
8 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
854
|
435K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
thestrategist5
|
854 |
435K |
1 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
854
|
435K
|
1
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Conversion of Performance Shares and Appendix 3Y x3
|
|
thestrategist5
|
40 |
8.0K |
4 |
24/07/20 |
24/07/20 |
ASX - By Stock
|
40
|
8.0K
|
4
|
|
ASX - By Stock
|
NME |
Re:
Ann: Placement
|
|
thestrategist5
|
16 |
4.4K |
4 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
16
|
4.4K
|
4
|
|
ASX - By Stock
|
NME |
Re:
Ann: Placement
|
|
thestrategist5
|
16 |
4.4K |
1 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
16
|
4.4K
|
1
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Launches Underwritten Share Purchase Plan
|
|
thestrategist5
|
79 |
26K |
1 |
16/06/20 |
16/06/20 |
ASX - By Stock
|
79
|
26K
|
1
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Suspension from Official Quotation
|
|
thestrategist5
|
101 |
43K |
0 |
22/05/20 |
22/05/20 |
ASX - By Stock
|
101
|
43K
|
0
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Pause in Trading
|
|
thestrategist5
|
61 |
21K |
0 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
61
|
21K
|
0
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Pause in Trading
|
|
thestrategist5
|
61 |
21K |
1 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
61
|
21K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Monday Opening Price
|
|
thestrategist5
|
312 |
157K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
312
|
157K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Monday Opening Price
|
|
thestrategist5
|
312 |
157K |
1 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
312
|
157K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Monday Opening Price
|
|
thestrategist5
|
312 |
157K |
2 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
312
|
157K
|
2
|
|
ASX - By Stock
|
WTC |
Re:
Ann: WTC 1H20 Results investor presentation
|
|
thestrategist5
|
328 |
2.7M |
0 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
328
|
2.7M
|
0
|
|
ASX - By Stock
|
WTC |
Re:
Ann: WTC 1H20 Results investor presentation
|
|
thestrategist5
|
328 |
2.7M |
3 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
328
|
2.7M
|
3
|
|
ASX - By Stock
|
WTC |
Re:
Ann: WTC 1H20 Results investor presentation
|
|
thestrategist5
|
328 |
2.7M |
2 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
328
|
2.7M
|
2
|
|
ASX - By Stock
|
WTC |
Re:
Ann: WTC 1H20 Results investor presentation
|
|
thestrategist5
|
328 |
2.7M |
3 |
20/02/20 |
20/02/20 |
ASX - By Stock
|
328
|
2.7M
|
3
|
|
ASX - By Stock
|
RAB |
Re:
Ann: Beating Guidance - Quarterly Activity Report & Appendix 4C
|
|
thestrategist5
|
49 |
40K |
2 |
16/01/20 |
16/01/20 |
ASX - By Stock
|
49
|
40K
|
2
|
|
ASX - By Stock
|
RAB |
Re:
Ann: Trading Halt
|
|
thestrategist5
|
21 |
10K |
12 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
21
|
10K
|
12
|
|
ASX - By Stock
|
RAB |
Re:
Ann: Trading Halt
|
|
thestrategist5
|
21 |
10K |
7 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
21
|
10K
|
7
|
|
ASX - By Stock
|
RAB |
Re:
Ann: Revenue Guidance for Q4 2019
|
|
thestrategist5
|
38 |
13K |
1 |
06/12/19 |
06/12/19 |
ASX - By Stock
|
38
|
13K
|
1
|
|
ASX - By Stock
|
RAB |
Re:
Ann: Commercialisation Update
|
|
thestrategist5
|
183 |
54K |
2 |
20/11/19 |
20/11/19 |
ASX - By Stock
|
183
|
54K
|
2
|
|
ASX - By Stock
|
RAB |
Re:
Ann: Commercialisation Update
|
|
thestrategist5
|
183 |
54K |
4 |
20/11/19 |
20/11/19 |
ASX - By Stock
|
183
|
54K
|
4
|
|
ASX - By Stock
|
GAS |
Re:
Ann: Trading Halt
|
|
thestrategist5
|
33 |
18K |
2 |
12/11/19 |
12/11/19 |
ASX - By Stock
|
33
|
18K
|
2
|
|
ASX - By Stock
|
WTC |
Re:
Ann: WTC responds to misinformation in market report
|
|
thestrategist5
|
137 |
62K |
0 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
137
|
62K
|
0
|
|
ASX - By Stock
|
WTC |
Re:
Ann: WTC responds to misinformation in market report
|
|
thestrategist5
|
137 |
62K |
2 |
23/10/19 |
23/10/19 |
ASX - By Stock
|
137
|
62K
|
2
|
|
ASX - By Stock
|
WTC |
Re:
Ann: WTC responds to misinformation in the market
|
|
thestrategist5
|
165 |
85K |
2 |
21/10/19 |
21/10/19 |
ASX - By Stock
|
165
|
85K
|
2
|
|
ASX - By Stock
|
WTC |
Re:
Ann: WTC responds to misinformation in the market
|
|
thestrategist5
|
165 |
85K |
2 |
21/10/19 |
21/10/19 |
ASX - By Stock
|
165
|
85K
|
2
|
|
ASX - By Stock
|
WTC |
Re:
Ann: Trading Halt
|
|
thestrategist5
|
12 |
13K |
3 |
18/10/19 |
18/10/19 |
ASX - By Stock
|
12
|
13K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment
|
|
thestrategist5
|
121 |
70K |
5 |
09/10/19 |
09/10/19 |
ASX - By Stock
|
121
|
70K
|
5
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Successfully Produces Bulk Lithium Chloride
|
|
thestrategist5
|
75 |
32K |
0 |
28/08/19 |
28/08/19 |
ASX - By Stock
|
75
|
32K
|
0
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Successfully Produces Bulk Lithium Chloride
|
|
thestrategist5
|
75 |
32K |
1 |
27/08/19 |
27/08/19 |
ASX - By Stock
|
75
|
32K
|
1
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Successfully Produces Bulk Lithium Chloride
|
|
thestrategist5
|
75 |
32K |
2 |
26/08/19 |
26/08/19 |
ASX - By Stock
|
75
|
32K
|
2
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Estimates Maiden JORC Mineral Resource
|
|
thestrategist5
|
94 |
69K |
2 |
17/06/19 |
17/06/19 |
ASX - By Stock
|
94
|
69K
|
2
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Closes SPP and Secures $15m Equity Facility
|
|
thestrategist5
|
126 |
49K |
2 |
20/05/19 |
20/05/19 |
ASX - By Stock
|
126
|
49K
|
2
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Closes SPP and Secures $15m Equity Facility
|
|
thestrategist5
|
126 |
49K |
15 |
20/05/19 |
20/05/19 |
ASX - By Stock
|
126
|
49K
|
15
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Assays 91% Higher Lithium Grades at Skyline Well
|
|
thestrategist5
|
82 |
31K |
4 |
11/03/19 |
11/03/19 |
ASX - By Stock
|
82
|
31K
|
4
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Produces Lithium Hydroxide Product
|
|
thestrategist5
|
129 |
50K |
2 |
03/10/18 |
03/10/18 |
ASX - By Stock
|
129
|
50K
|
2
|
|
ASX - By Stock
|
ASN |
Re:
Good old fireside chat
|
|
thestrategist5
|
14K |
7.3M |
9 |
30/08/18 |
30/08/18 |
ASX - By Stock
|
14K
|
7.3M
|
9
|
|
ASX - By Stock
|
ASN |
Re:
Good old fireside chat
|
|
thestrategist5
|
14K |
7.3M |
1 |
30/08/18 |
30/08/18 |
ASX - By Stock
|
14K
|
7.3M
|
1
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Site Tests Correlate with Laboratory Evaporation Work
|
|
thestrategist5
|
55 |
21K |
22 |
25/07/18 |
25/07/18 |
ASX - By Stock
|
55
|
21K
|
22
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Site Tests Correlate with Laboratory Evaporation Work
|
|
thestrategist5
|
55 |
21K |
7 |
25/07/18 |
25/07/18 |
ASX - By Stock
|
55
|
21K
|
7
|
|
ASX - By Stock
|
ASN |
Re:
Good old fireside chat
|
|
thestrategist5
|
14K |
7.3M |
16 |
18/07/18 |
18/07/18 |
ASX - By Stock
|
14K
|
7.3M
|
16
|
|
ASX - By Stock
|
ASN |
Re:
Good old fireside chat
|
|
thestrategist5
|
14K |
7.3M |
3 |
20/04/18 |
20/04/18 |
ASX - By Stock
|
14K
|
7.3M
|
3
|
|
ASX - By Stock
|
ASN |
Re:
A missed opportunity
|
|
thestrategist5
|
38 |
21K |
9 |
20/04/18 |
20/04/18 |
ASX - By Stock
|
38
|
21K
|
9
|
|